Parvalbumin (Pv) Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Parvalbumin (PV) neurons are a major class of GABAergic inhibitory interneurons characterized by their expression of the calcium-binding protein parvalbumin. These fast-spiking neurons play crucial roles in cortical and hippocampal circuitry, particularly in generating gamma oscillations (30-80 Hz) essential for cognitive processes including attention, memory, and sensory processing[1].
In neurodegeneration, PV neurons are prominently affected in Alzheimer's disease, Parkinson's disease, and various forms of epilepsy that accompany neurodegenerative conditions. Their dysfunction contributes to network hypersynchrony, epileptiform activity, and cognitive decline[2].
PV neurons are distributed throughout the cerebral cortex, hippocampus, amygdala, basal ganglia, and cerebellum. In the neocortex, they represent approximately 20-25% of all GABAergic interneurons and are classified into two main morphological types[3]:
PV neurons possess the following distinguishing features:
Parvalbumin is a EF-hand calcium-binding protein with rapid kinetics, allowing PV neurons to handle high-frequency firing without calcium overload. This enables sustained high-frequency action potential generation essential for gamma oscillation maintenance[4].
PV neurons express:
PV neurons are the primary cellular substrate for gamma oscillations through reciprocal inhibition and electrical coupling. Their fast-spiking properties and dense perisomatic innervation enable synchronized inhibition that orchestrates pyramidal neuron firing patterns[5].
PV neurons receive input from:
During early development, PV neuron maturation marks critical periods for sensory map formation. PV neuron dysfunction can prolong or reopen critical periods inappropriately.
PV neuron abnormalities in AD include[6]:
PV neurons are affected in PD through:
PV neuron loss is a hallmark of temporal lobe epilepsy:
PV neuron-protective strategies include[7]:
Non-invasive gamma stimulation (40 Hz) is being investigated:
The study of Parvalbumin (Pv) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Bartos M, Vida I, Jonas P. Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci. 2007;8(1):45-56. PMID:17193262. ↩︎
Palop JJ, Mucke L. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci. 2016;17(12):777-792. PMID:27829687. ↩︎
Rudy B, Fishell G, Lee S, Hjerling-Leffler J. Three groups of interneurons regulate circuitry in the cortex. Nat Neurosci. 2011;14(3):278-285. PMID:21362588. ↩︎
Schwaller B, Tetko IV, Tandon P, et al. Parvalbumin deficiency affects network properties resulting in increased susceptibility to pentylenetetrazol-induced seizure attacks in mice. Learn Mem. 2004;11(4):461-470. PMID:15286184. ↩︎
Sohal VS, Zhang F, Yizhar O, Deisseroth K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature. 2009;459(7247):698-702. PMID:19396159. ↩︎
Verret L, Mann EO, Hang GB, et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell. 2012;149(3):708-721. PMID:22541439. ↩︎
Bianchi S, Lazari S, Pavone F, et al. Targeting parvalbumin interneurons for brain disorders: promises and limitations. Prog Neuropsychopharmacol Biol Psychiatry. 2021;111:110341. PMID:33862303. ↩︎